Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis

被引:0
|
作者
Yujia Wang
Lushuang Xu
Yang Liu
Yuzhe Hu
Qiang Shi
Lixue Jin
Lijun Yang
Pingzhang Wang
Kunshan Zhang
Xiaojun Huang
Qing Ge
Jin Lu
机构
[1] Peking University,Department of Immunology, School of Basic Medical Sciences, NHC Key Laboratory of Medical Immunology
[2] Peking University People’s Hospital and Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation
[3] Peking University,School of Life Sciences, Center for Bioinformatics
[4] Tongji Hospital,Translational Stem Cell Research Center
[5] Tongji University School of Medicine,Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences
[6] Peking University,Collaborative Innovation Center of Haematology
[7] Soochow University,undefined
[8] Peking University Health Sciences Center,undefined
来源
关键词
Immunoglobulin light chain amyloidosis; Single-cell RNA sequencing; Plasma cells; Natural killer cells;
D O I
暂无
中图分类号
学科分类号
摘要
Immunoglobulin light chain amyloidosis (AL amyloidosis) is characterized by the presence of B cells producing amyloidogenic immunoglobulin light chains (LCs). The low frequency of aberrant B cells in AL is often masked by a polyclonal B cell background, making it difficult for treatment. We analyzed the single-cell RNA sequencing data from GEO database to compare the plasma cell (PCs) in four individuals with AL amyloidosis, one AL subject after treatment, and six healthy controls. High interindividual variability in AL-derived PCs in their expression pattern of known overexpressed genes in multiple myeloma and their usage of V regions in LCs was demonstrated. We also found overexpression of MHC class I molecules as one of the common features of clonal PCs in individuals with AL amyloidosis. Significantly reduced frequencies of circulating natural killer (NK) cells were also observed in a small cohort of AL patients when compared to healthy controls. These data demonstrate that aberrant PCs in AL has a highly diverse transcriptome, an upregulation of MHC, and a dampened capability of immunosurveillance by reduction of circulating NK frequencies. The analysis of clonal PCs at single cell level may provide a better approach for precise molecular profiling and diagnosis of AL amyloidosis.
引用
收藏
页码:231 / 242
页数:11
相关论文
共 50 条
  • [1] Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis
    Wang, Yujia
    Xu, Lushuang
    Liu, Yang
    Hu, Yuzhe
    Shi, Qiang
    Jin, Lixue
    Yang, Lijun
    Wang, Pingzhang
    Zhang, Kunshan
    Huang, Xiaojun
    Ge, Qing
    Lu, Jin
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (02) : 231 - 242
  • [2] Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
    Cuenca, Isabel
    Alameda, Daniel
    Sanchez-Vega, Beatriz
    Gomez-Sanchez, David
    Alignani, Diego
    Lasa, Marta
    Onecha, Esther
    Lecumberri, Ramon
    Prosper, Felipe
    Ocio, Enrique M.
    Gonzalez, Maria Esther
    de Coca, Alfonso
    de la Rubia, Javier
    Gironella, Mercedes
    Palomera, Luis
    Oriol, Albert
    Casanova, Maria
    Cabanas, Valentin
    Taboada, Francisco
    Perez-Montana, Albert
    De Arriba, Felipe
    Puig, Noemi
    Carreno-Tarragona, Gonzalo
    Barrio, Santiago
    de la Puerta, Jose
    Ramirez-Payer, Angel
    Krsnik, Isabel
    Bargay, Juan Jose
    Lahuerta, Juan Jose
    Mateos, Maria-Victoria
    San-Miguel, Jesus F.
    Paiva, Bruno
    Lopez, Joaquin Martinez
    [J]. LEUKEMIA, 2021, 35 (01) : 245 - 249
  • [3] Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
    Isabel Cuenca
    Daniel Alameda
    Beatriz Sanchez-Vega
    David Gomez-Sanchez
    Diego Alignani
    Marta Lasa
    Esther Onecha
    Ramon Lecumberri
    Felipe Prosper
    Enrique M. Ocio
    Maria Esther González
    Alfonso García de Coca
    Javier De La Rubia
    Mercedes Gironella
    Luis Palomera
    Albert Oriol
    Maria Casanova
    Valentin Cabañas
    Francisco Taboada
    Albert Pérez-Montaña
    Felipe De Arriba
    Noemi Puig
    Gonzalo Carreño-Tarragona
    Santiago Barrio
    Jose Enrique de la Puerta
    Angel Ramirez-Payer
    Isabel Krsnik
    Juan Jose Bargay
    Juan Jose Lahuerta
    Maria-Victoria Mateos
    Jesus F. San-Miguel
    Bruno Paiva
    Joaquin Martinez-Lopez
    [J]. Leukemia, 2021, 35 : 245 - 249
  • [4] Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis
    Paiva, Bruno
    Martinez-Lopez, Joaquin
    Corchete, Luis A.
    Sanchez-Vega, Beatriz
    Rapado, Inmaculada
    Puig, Noemi
    Barrio, Santiago
    Sanchez, Maria-Luz
    Alignani, Diego
    Lasa, Marta
    Garcia de Coca, Alfonso
    Pardal, Emilia
    Oriol, Alberto
    Gonzalez Garcia, Maria-Esther
    Escalante, Fernando
    Gonzalez-Lopez, Tomas J.
    Palomera, Luis
    Alonso, Jose
    Prosper, Felipe
    Orfao, Alberto
    Vidriales, Maria-Belen
    Mateos, Maria-Victoria
    Lahuerta, Juan-Jose
    Gutierrez, Norma C.
    San Miguel, Jesus F.
    [J]. BLOOD, 2016, 127 (24) : 3035 - 3039
  • [5] Deciphering the transcriptional and clonal heterogeneity of adaptive immune cells in inflammation
    Mashreghi, Mir-Farzin
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 16 - 16
  • [6] Immunoglobulin light chain amyloidosis
    Merlini, Giampaolo
    Comenzo, Raymond L.
    Seldin, David C.
    Wechalekar, Ashutosh
    Gertz, Morie A.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (01) : 143 - 156
  • [7] Clonal hematopoiesis of indeterminate potential in patients with immunoglobulin light-chain AL amyloidosis
    Lopedote, Paolo
    Evans, Benjamin
    Marchetti, Alfredo
    Chen, Tianzeng
    Moscvin, Maria
    Boullt, Samuel
    Bolli, Niccolo
    Bianchi, Giada
    [J]. BLOOD ADVANCES, 2024, 8 (13) : 3427 - 3436
  • [8] Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis
    Weiss, Brendan M.
    Wong, Sandy W.
    Comenzo, Raymond L.
    [J]. BLOOD, 2016, 127 (19) : 2275 - 2280
  • [9] Treatment of immunoglobulin light chain amyloidosis
    Gertz M.A.
    Zeldenrust S.R.
    [J]. Current Hematologic Malignancy Reports, 2009, 4 (2) : 91 - 98
  • [10] Systemic immunoglobulin light chain amyloidosis
    Giampaolo Merlini
    Angela Dispenzieri
    Vaishali Sanchorawala
    Stefan O. Schönland
    Giovanni Palladini
    Philip N. Hawkins
    Morie A. Gertz
    [J]. Nature Reviews Disease Primers, 4